lek. Zuzanna Pawlus-Ruszel

ORCID: 0000-0001-5228-4234

The topic of my dissertation is: “Efficacy of guselkumab in the treatment of psoriasis-associated pruritus“

My research focuses on pruritus, one of the most common and burdensome symptoms of psoriasis, and its response to treatment with guselkumab, a biologic therapy targeting interleukin-23. I aim to evaluate the effectiveness of guselkumab in reducing the severity of pruritus in patients with moderate-to-severe plaque psoriasis and to assess the dynamics of the antipruritic response during treatment.

My study will include patients with plaque psoriasis initiating treatment with guselkumab. In addition to assessing pruritus severity, I will evaluate psoriasis severity and extent, quality of life, symptoms of anxiety and depression, and the level of disease-related stigmatization using validated clinical scales and questionnaires. I will also investigate the relationship between improvement in pruritus and clinical response to treatment, as well as identify patient characteristics associated with the best antipruritic response.

Through this research, I aim to provide a more comprehensive understanding of the effect of guselkumab on psoriasis-associated pruritus and its impact on patients’ quality of life. The findings may contribute to better patient selection for biologic therapy and support a more individualized and patient-centered approach to psoriasis treatment.

I am a member of Polish Society of Dermatology,  European Academy of Dermatology and Venerology and International Society of Dermatology.

Based on Research Gate I have published 14 papers and my h-index is 3 

 

The most important publication:

1. Pawlus Z, Wojtowicz I, Kaznowska E, Reich A, Żychowska M. Necrobiotic Xanthogranuloma (NXG): Dermoscopic and Reflectance Confocal Microscopic Findings and Review of Treatment with Intravenous Immunoglobulin (IVIG). Dermatol Ther (Heidelb). 2026 Jul 23. doi: 10.1007/s13555-026-01868-x. Epub ahead of print. PMID: 42493693.

2. Kruczek W, Frątczak A, Litwińska-Inglot I, Polak K, Pawlus Z, Rutecka P, Bergler-Czop B, Miziołek B Comparative Analysis of the Long-Term Real-World Efficacy of Interleukin-17 Inhibitors in a Cohort of Patients with Moderate-to-Severe Psoriasis Treated in Poland, Journal of Clinical Medicine, https://doi.org/ 10.3390/jcm14155421

3.  Kruczek W, Pawlus Z, Rutecka P, Kozik A, Frątczak A, Pietrauszka K, Śnietura M, Bergler-Czop B, Melanoma concealed by tattoos: Analysis of ink pigmentation and advanced diagnostic methodologies, Journal of The European Academy of Dermatology and Venerology, doi.org/10.1111/jdv.20730

4.  Pawlus Z, Spyra A, Polak K, Miziołek B, Bergler-Czop B. Can social media encourage young Polish adults to visit a dermatologist? An original study. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2025;42(1):68-74. doi:10.5114/ada.2025.147554.

5. Fratczak A, Spyra A, Pawlus Z, Polak K, Bergler-Czop B. Botulinum toxin on a mission to erase keloids: does the dream come true? Postepy Dermatol Alergol. 2025 Oct 20;42(5):433-438. doi: 10.5114/ada.2025.155421.

6. Łanocha M, Spyra A, Pawlus Z, Miziołek B, Bergler-Czop B, A case report of disseminated Kaposi sarcoma with spontaneous regression in a HIV-negative patient: classic or drug-induced variant? Dermatol Rev/Przegl Dermatol https://doi.org/10.5114/dr.2025.152176

7. Pawlus Z, Kruczek W, Reizer R, Dzierwa A, Frątczak A, Bergler-Czop B “Measurements of surface textures in dermatology - A review” Measurement https://doi.org/10.1016/j.measurement.2025.118943

8. Mandecka A, Pawlus Z, Kruczek W et al. Graham–Little–Piccardi–Lassueur syndrome: case report and systematic review of a rare LPP variant. Forum Dermatologicum. 2026;12:e05026051. doi:10.5603/fd.111978.

9. Pawlus Z, Spyra A, Tekielak A, Polak K, Frątczak A, Bergler-Czop B. Unmasking genital herpes zoster: A systematic review of the literature. Forum Dermatologicum. 2026;12:e05026028. doi:10.5603/fd.108157.